A SURVEY OF CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE IN COMPANION
|
|
- Laureen Sherman
- 6 years ago
- Views:
Transcription
1 AAC Accepted Manuscript Posted Online 11 January 2016 Antimicrob. Agents Chemother. doi: /aac Copyright 2016, American Society for Microbiology. All Rights Reserved A SURVEY OF CARBAPENEMASE PRODUCING ENTEROBACTERIACEAE IN COMPANION DOGS IN MADRID, SPAIN Ana González-Torralba a,b, Jesús Oteo d, Alejandra Asenjo a, Verónica Bautista d, Elisabeth Fuentes c, Juan-Ignacio Alós* a,b a Servicio de Microbiología, Hospital Universitario de Getafe, Getafe, Madrid. b Universidad Europea, Villaviciosa de Odón, Madrid. c Hospital Veterinario Vetsia, Fuenlabrada, Madrid. d Laboratorio de Resistencia a Antibióticos, Centro Nacional de Microbiología, Instituto de Salud Carlos III, Majadahonda, Madrid, Spain Keywords: carbapenemases, Enterobacteriaceae, companion animals Running title: CARBAPENEMASES IN COMPANION DOGS IN SPAIN *Corresponding author: Dr. Juan-Ignacio Alós Servicio de Microbiología, Hospital Universitario Getafe Carretera de Toledo km 12,500, Getafe, Madrid, Spain. Phone number: (34) address: nachoalos@telefonica.net
2 Abstract We found a low prevalence (0.6%) of carbapenemase-producing Enterobacteriaceae (CPE) in fecal microbiota of companion dogs. A single VIM-1-producing K. pneumoniae isolate belonging to the ST2090 was detected. bla VIM-1 was carried on a class 1 integron and an untypable ~ 48 kb plasmid. Emergence and spread of CPE in this group of animals may represent a threat to public health in human and veterinary medicine. This finding supports the need of active surveillance studies in companion animals that live close to humans as interspecies transmission may occur within the same household. 34 Text The emergence and worldwide spread of carbapenemase-producing Enterobacteriaceae (CPE) have significantly increased in recent years mainly in K. pneumoniae (1-3). Most carbapenemases are encoded on mobile genetic elements (4) which usually contain other antimicrobial resistance genes. CPE and other carbapenemase-producing bacteria, which seemed limited to humans, have also been described in animals, particularly in livestock. The detection of Pseudomonas aeruginosa with VIM-2, and Acinetobacter baumannii with OXA-23 and OXA-58 in livestock animals from Lebanon (5) was recently reported. Several VIM-1 carbapenemase producing E. coli and Salmonella isolates were recovered from pigs in Germany (6, 7), Acinetobacter spp harboring OXA-23 was isolated from cattle in France (8), and A. baumannii and Acinetobacter lwoffii isolates producing NDM-1 were detected from porcine and chicken sources in China (9). In addition, NDM-1 producing Salmonella enterica subsp. enterica serovar Corvallis was reported in Germany from a
3 wild bird (10). Only exceptionally CPE have been found in pets, specifically in three studies which detected OXA-48 producing E. coli and K. pneumoniae from dogs in Germany (11), NDM-1 producing E. coli from dogs and cats in the U.S.A (12), and OXA- 23 producing Acinetobacter spp. from horses in Belgium (13). Since there is very little information about CPE in companion animals, here we describe a study aimed to assess the prevalence of CPE in rectal swabs from companion dogs. Between October 2014 and January 2015, 160 rectal swabs from different dogs who attended a veterinary hospital in Fuenlabrada (Madrid, Spain) were collected without any inclusion or exclusion criteria by inserting a swab into the rectum while rotating it. The swab was then transported to the laboratory in Amies medium. At the time of swab collection 54% of the animals were under antibiotic treatment. The drugs used as monotherapy were in order of frequency amoxicillin-clavulanic acid (18,6%), cephalexin (15,1%), metronidazole (9,3%), marbofloxacin (8,1%), sulfadoxinetrimethoprim (SxT) (7%), ampicillin (4,7%), amoxicillin (3,5%), cefazolin (1,2%), nitrofurantoin (1,2%) and azithromycin (1,2%). Antibiotic combinations included metronidazole + cephalexin (7%), amoxicillin-clavulanic acid + marbofloxacin (5,8%), cephalexin + marbofloxacin (3,5%), metronidazole + marbofloxacin (3,5%), metronidazole + marbofloxacin + cephalexin (3,5%), metronidazole + SxT (2,3%), amoxicillin-clavulanic acid + metronidazole (1,2%), amoxicillin-clavulanic acid + SxT (1,2%), marbofloxacin + azithromycin (1,2%) and ampicillin + marbofloxacin (1,2%) Samples were inoculated on a selective chromogenic media bi-plate (chromid CARBA SMART, biomérieux) which consists of an association of media to screen for OXA-48 on one side, and other carbapenemases on the other side. Plates were then incubated at
4 C for 24 h in aerobic atmosphere. Susceptibility testing and identification were performed on every isolate with growth on this media using WIDER system (Francisco Soria Melguizo) Phenotypic carbapenemase characterization was conducted, according to the susceptibility testing results, on those isolates that matched the EUCAST screening criteria (14) using the combination disk test (ROSCO ) which includes meropenem (10 µg) alone and combined with boronic acid (BO), cloxacillin (CX) and dipicolinic acid (DPA). A temocillin disk (30 µg) was used as a phenotypic indicator of OXA In addition, those isolates with growth on chromid CARBA SMART but with negative results for carbapenemase-production were further investigated for the presence of extended-spectrum β-lactamases (ESBL) and/or AmpC-type enzymes according to EUCAST guidelines (14). The phenotypic confirmation method used was the combination disk test which included a disk containing cefotaxime (30 µg) alone and in combination with clavulanic acid, cloxacilin, and cloxacilin-clavulanic acid (ROSCO ). Furthermore, the double-disk synergy test, which included a disk containing cefepime and another one containing clavulanic acid, was performed to confirm the presence of ESBL in those Enterobacteriaceae with inducible chromosomal AmpC The presence of genes encoding carbapenemases (bla OXA-48, bla KPC, bla VIM, bla IMP, and bla NDM ) (15), ESBLs (bla TEM, bla SHV, and bla CTX-M ) (16) and plasmid-mediated AmpC (bla CMY, bla FOX, bla MOX, bla DHA, bla EBC bla ACC ) (17) was determined using PCR and DNA sequencing assays. The sequences obtained were compared with those available in the public databases GenBank and Lahey Clinic (
5 Multilocus sequence typing (MLST) was performed for all carbapenemase-producing isolates using the Institut Pasteur scheme Class 1 integron structures, the integrase gene inti1 and the variable regions, were screened by PCR amplification and DNA sequencing (18). Conjugation experiments were performed with carbapenemase-producing K. pneumoniae isolate using the kanamycin-azide resistant E. coli Hb101 as a recipient. Putative transconjugants were selected on Mueller-Hinton agar plates containing kanamycin (100 μg/ml), azide (160 μg/ml), and cefotaxime (4 μg/ml). Plasmids were classified according to their incompatibility group by a PCR-based replicon-typing scheme (19). PFGE with S1 nuclease digestion of whole genomic DNA (S1-PFGE) was used to detect plasmids as previously described (20) Three Enterobacteriaceae from three different dogs grew on the selective chromogenic media bi-plate: 2 Klebsiella pneumoniae (named 1 and 2 ) and 1 Enterobacter cloacae. Only K. pneumoniae-1 produced carbapenemase and the remaining isolates were considered false-positives on the chromid CARBA SMART medium. Susceptibility testing results are listed on Table 1. The combination disk test showed a profile compatible with CPE in the K. pneumoniae-1 isolate confirmed by PCR and sequencing as a metallo- β-lactamase VIM-1, belonging to the new sequence type (ST) 2090, not related to any ST previously described. This isolate, also resistant to trimethoprim-sulfamethoxazole, tobramycin and fosfomycin, was detected in a dog from an animal shelter without any medication at the time of sampling neither in the
6 previous month. The presence of genes encoding ESBLs or plasmid-mediated AmpC were not detected in this isolate bla VIM-1 gene was carried on a class 1 integron in the following cassette combination: inti1 (integrase gene) - bla VIM-1 - aac(6 )-Ib (tobramycin-resistance gene, also called aaca4) dfrb1 (thrimethoprim-resistance gene) - aada1 (streptomycin-resistance gene) - catb2 (chloramphenicol-resistance) - qaceδ1/sul1 (quaternary ammonium compounds-resistance gene/sulphonamides-resistance gene). Carbapenem-nonsusceptible E. coli transconjugant was obtained from VIM-1-producing K. pneumoniae isolate. Both, isolate from surveillance and transconjugant, carried a plasmid of ~ 48 kb that was untypeable by PCR. In addition, transconjugant was positive for class 1 integron and bla VIM. VIM-1-producing E. coli transconjugant presented also reduced susceptibility to tobramycin, and trimethoprim-sulfamethoxazole but not to fosfomycin According to the results, the K. pneumoniae-2 strain was further investigated as it seemed to harbor an ESBL and a plasmidic AmpC enzyme, confirmed as CTX-M-15 and DHA, respectively. It belonged to a dog that was being treated with marbofloxacin and amoxicillin-clavulanate The double-disk synergy test with cefepime and amoxicillin-clavulanic acid was positive for the E. cloacae strain, suggesting the ESBL production confirmed as SHV-12 by sequencing. No genes encoding carbapenemases were detected by PCR. The dog was receiving cephalexin and metronidazole at the time of sampling.
7 The isolation of multidrug resistant Enterobacteriaceae in companion animals is an emerging phenomenon. There are few studies describing colonization or infection of companion animals with these organisms, but the number seems to be increasing. According to a recent review (21) and similarly to humans (22), CTX-M type ESBL are the most prevalent, essentially CTX-M-1, 14 and 15, although SHV-12 and TEM-52 have also been described, mostly detected in E.coli and in K. pneumoniae strains from cats and dogs; CMY-2 and DHA are the most common AmpC β-lactamases described so far (21). Fortunately, carbapenemases are exceptionally rare in companion animals (11-13). In veterinary medicine, β-lactam antibiotics are the most widely used for bacterial infections(21). In dogs, first generation cephalosporins and amoxicillin/clavulanic acid are among the most commonly prescribed (23). Nevertheless, the use of cabapenems is not currently licenced although it has been reported exceptionally (24). Therefore resistance to carbapenems is not routinely evaluated in animal isolates, so it seems likely that its prevalence is underestimated (11) However, although the use of carbapenems is not a common practice, the presence of genes encoding carbapenemases in mobile genetic elements, that can also include other antibiotic resistance genes, means that the use of other antimicrobials could contribute to co-selection (6). The detection of genes conferring resistance to aminoglycosides, trimethoprim and sulphonamides in the same class 1 integron with bla VIM-1 could facilitate that co-selection phenomenon The great increase and spread of CPE from human sources and its recent isolation from animals may reflect an emerging problem both in human and veterinary medicine as interspecies transmission may occur between humans and companion animals within
8 the same household (25). Our results support this hypothesis as the class 1 integron and plasmid carrying bla VIM-1 detected in this study are among the most frequent mobile genetic elements associated to bla VIM-1 dissemination in humans (26) In Spain the isolation of CPE in humans has significantly increased in recent years. According to a recent multicenter Spanish study including 83 hospitals, OXA-48 carbapenemase is currently the most prevalent in our country followed by VIM-1 which appears much less frequently (27). The estimated overall prevalence of infection by carbapenemase-producing K. pneumoniae was 1.7% (range per hospital: %), and 23 (30.7%) hospitals had a prevalence >1% (27). In the present study we found a 0.6% CPE prevalence in companion dogs Emergence and spread of CPE in companion animals may represent an underestimated threat to public health. Our findings support probable human-animals transference of carbapenemases genes and reveal the need of active surveillance studies in companion animals. 174 Acknowledgements We thank the Antibiotic Resistance Surveillance Program of the Spanish National Center of Microbiology (Instituto de Salud Carlos III, Ministerio de Economía y Competitividad) for support with molecular characterization. 178 References Canton R, Akova M, Carmeli Y, Giske CG, Glupczynski Y, Gniadkowski M, Livermore DM, Miriagou V, Naas T, Rossolini GM, Samuelsen O, Seifert H, Woodford N, Nordmann P Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. Clin Microbiol Infect 18: Nordmann P, Naas T, Poirel L Global spread of Carbapenemase-producing Enterobacteriaceae. Emerg Infect Dis 17:
9 Tzouvelekis LS, Markogiannakis A, Psichogiou M, Tassios PT, Daikos GL Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions. Clin Microbiol Rev 25: Carattoli A Plasmids and the spread of resistance. Int J Med Microbiol 303: Al Bayssari C, Dabboussi F, Hamze M, Rolain JM Emergence of carbapenemaseproducing Pseudomonas aeruginosa and Acinetobacter baumannii in livestock animals in Lebanon. J Antimicrob Chemother 70: Fischer J, Rodriguez I, Schmoger S, Friese A, Roesler U, Helmuth R, Guerra B Salmonella enterica subsp. enterica producing VIM-1 carbapenemase isolated from livestock farms. J Antimicrob Chemother 68: Fischer J, Rodriguez I, Schmoger S, Friese A, Roesler U, Helmuth R, Guerra B Escherichia coli producing VIM-1 carbapenemase isolated on a pig farm. J Antimicrob Chemother 67: Poirel L, Bercot B, Millemann Y, Bonnin RA, Pannaux G, Nordmann P Carbapenemase-producing Acinetobacter spp. in Cattle, France. Emerg Infect Dis 18: Zhang WJ, Lu Z, Schwarz S, Zhang RM, Wang XM, Si W, Yu S, Chen L, Liu S Complete sequence of the bla(ndm-1)-carrying plasmid pndm-ab from Acinetobacter baumannii of food animal origin. J Antimicrob Chemother 68: Fischer J, Schmoger S, Jahn S, Helmuth R, Guerra B NDM-1 carbapenemaseproducing Salmonella enterica subsp. enterica serovar Corvallis isolated from a wild bird in Germany. J Antimicrob Chemother 68: Stolle I, Prenger-Berninghoff E, Stamm I, Scheufen S, Hassdenteufel E, Guenther S, Bethe A, Pfeifer Y, Ewers C Emergence of OXA-48 carbapenemase-producing Escherichia coli and Klebsiella pneumoniae in dogs. J Antimicrob Chemother 68: Shaheen BW, Nayak R, Boothe DM Emergence of a New Delhi metallo-betalactamase (NDM-1)-encoding gene in clinical Escherichia coli isolates recovered from companion animals in the United States. Antimicrob Agents Chemother 57: Smet A, Boyen F, Pasmans F, Butaye P, Martens A, Nemec A, Deschaght P, Vaneechoutte M, Haesebrouck F OXA-23-producing Acinetobacter species from horses: a public health hazard? J Antimicrob Chemother 67: European Society of Clinical Microbiology and Infectious Diseases. EUCAST Guidelines for Detection of Resistance Mechanisms and Specific Resistances of Clinical and/or Epidemiological Importance Version _guidelines_detection_of_resistance_mechanisms_ pdf (5th January 2015, date last accessed). 15. Oteo J, Saez D, Bautista V, Fernandez-Romero S, Hernandez-Molina JM, Perez- Vazquez M, Aracil B, Campos J Carbapenemase-producing Enterobacteriaceae in Spain in Antimicrob Agents Chemother 57: Oteo J, Navarro C, Cercenado E, Delgado-Iribarren A, Wilhelmi I, Orden B, Garcia C, Miguelanez S, Perez-Vazquez M, Garcia-Cobos S, Aracil B, Bautista V, Campos J Spread of Escherichia coli strains with high-level cefotaxime and ceftazidime resistance between the community, long-term care facilities, and hospital institutions. J Clin Microbiol 44: Perez-Perez FJ, Hanson ND Detection of plasmid-mediated AmpC betalactamase genes in clinical isolates by using multiplex PCR. J Clin Microbiol 40:
10 Sunde M Prevalence and characterization of class 1 and class 2 integrons in Escherichia coli isolated from meat and meat products of Norwegian origin. J Antimicrob Chemother 56: Carattoli A, Bertini A, Villa L, Falbo V, Hopkins KL, Threlfall EJ Identification of plasmids by PCR-based replicon typing. J Microbiol Methods 63: Garcia A, Navarro F, Miro E, Villa L, Mirelis B, Coll P, Carattoli A Acquisition and diffusion of bla CTX-M-9 gene by R478-IncHI2 derivative plasmids. FEMS Microbiol Lett 271: Rubin JE, Pitout JD Extended-spectrum beta-lactamase, carbapenemase and AmpC producing Enterobacteriaceae in companion animals. Vet Microbiol 170: Canton R, Gonzalez-Alba JM, Galan JC CTX-M Enzymes: Origin and Diffusion. Front Microbiol 3: Murphy CP, Reid-Smith RJ, Boerlin P, Weese JS, Prescott JF, Janecko N, McEwen SA Out-patient antimicrobial drug use in dogs and cats for new disease events from community companion animal practices in Ontario. Can Vet J 53: Abraham S, Wong HS, Turnidge J, Johnson JR, Trott DJ Carbapenemaseproducing bacteria in companion animals: a public health concern on the horizon. J Antimicrob Chemother 69: Johnson JR, Clabots C, Kuskowski MA Multiple-host sharing, long-term persistence, and virulence of Escherichia coli clones from human and animal household members. J Clin Microbiol 46: Zamorano L, Miro E, Juan C, Gomez L, Bou G, Gonzalez-Lopez JJ, Martinez-Martinez L, Aracil B, Conejo MC, Oliver A, Navarro F Mobile genetic elements related to the diffusion of plasmid-mediated AmpC beta-lactamases or carbapenemases from Enterobacteriaceae: findings from a multicenter study in Spain. Antimicrob Agents Chemother 59: Oteo J, Ortega A, Bartolome R, Bou G, Conejo C, Fernandez-Martinez M, Gonzalez- Lopez JJ, Martinez-Garcia L, Martinez-Martinez L, Merino M, Miro E, Mora M, Navarro F, Oliver A, Pascual A, Rodriguez-Bano J, Ruiz-Carrascoso G, Ruiz-Garbajosa P, Zamorano L, Bautista V, Perez-Vazquez M, Campos J Prospective multicenter study of carbapenemase-producing Enterobacteriaceae from 83 hospitals in Spain reveals high in vitro susceptibility to colistin and meropenem. Antimicrob Agents Chemother 59:
11 Table 1. MIC (mg/l) of β-lactam antibiotics. K. pneumoniae 1 K. pneumoniae 2 E. cloacae Amoxicillin >16 >16 >16 Amoxicillin-clavulanic acid >16/8 >16/8 >16/8 Piperacillin/tazobactam >64/4 >64/4 >64/4 Cefuroxime >16 >16 >16 Cefoxitin >16 >16 >16 Ceftazidime >16 >16 >16 Ceftazidime- clavulanic acid >8/4 >8/4 >8/4 Cefotaxime >8 >8 >8 Cefotaxime- clavulanic acid >8/4 >8/4 >8/4 Cefepime >8 >8 >8 Aztreonam 1 >8 >8 Imipenem Meropenem Ertapenem
EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM)
EUCAST Subcommitee for Detection of Resistance Mechanisms (ESDReM) Christian G. Giske, MD/PhD Chairman of ESDReM Karolinska University Hospital and EUCAST ECCMID, 22 maj 2013 The background Guidance on
More informationPresence of extended spectrum β-lactamase producing Escherichia coli in
1 2 Presence of extended spectrum β-lactamase producing Escherichia coli in wild geese 3 4 5 A. Garmyn* 1, F. Haesebrouck 1, T. Hellebuyck 1, A. Smet 1, F. Pasmans 1, P. Butaye 2, A. Martel 1 6 7 8 9 10
More information1 INTRODUCTION OBJECTIVES OUTLINE OF THE SALM/CAMP EQAS
PROTOCOL For antimicrobial susceptibility testing of Salmonella, Campylobacter and optional genotypic characterisation of AmpC-, ESBL- and carbapenemase-producing test strains 1 INTRODUCTION... 1 2 OBJECTIVES...
More informationFlorida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC
Florida Health Care Association District 2 January 13, 2015 A.C. Burke, MA, CIC 11/20/2014 1 To describe carbapenem-resistant Enterobacteriaceae. To identify laboratory detection standards for carbapenem-resistant
More informationESCMID Online Lecture Library. by author
Expert rules in susceptibility testing EUCAST-ESGARS-EPASG Educational Workshop Linz, 16 19 September, 2014 Dr. Rafael Cantón Hospital Universitario Ramón y Cajal SERVICIO DE MICROBIOLOGÍA Y PARASITOLOGÍA
More informationExtended-Spectrum CTX-M-15-Producing Klebsiella pneumoniae. ST274 in Companion Animals
AAC Accepts, published online ahead of print on 19 February 2013 Antimicrob. Agents Chemother. doi:10.1128/aac.02622-12 Copyright 2013, American Society for Microbiology. All Rights Reserved. 1 2 3 AAC02622-12
More informationOther β-lactamase Inhibitor (BLI) Combinations: Focus on VNRX-5133, WCK 5222 and ETX2514SUL
Other β-lactamase Inhibitor (BLI) Combinations: Focus on VNRX-5133, WCK 5222 and ETX2514SUL David P. Nicolau, PharmD, FCCP, FIDSA Director, Center for Anti-Infective Research and Development Hartford Hospital
More informationPrevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia
Prevalence of Extended-spectrum β-lactamase Producing Enterobacteriaceae Strains in Latvia Ruta Paberza 1, Solvita Selderiņa 1, Sandra Leja 1, Jelena Storoženko 1, Lilija Lužbinska 1, Aija Žileviča 2*
More informationPrevalence of Metallo-Beta-Lactamase Producing Pseudomonas aeruginosa and its antibiogram in a tertiary care centre
International Journal of Current Microbiology and Applied Sciences ISSN: 2319-7706 Volume 4 Number 9 (2015) pp. 952-956 http://www.ijcmas.com Original Research Article Prevalence of Metallo-Beta-Lactamase
More informationAntimicrobial Cycling. Donald E Low University of Toronto
Antimicrobial Cycling Donald E Low University of Toronto Bad Bugs, No Drugs 1 The Antimicrobial Availability Task Force of the IDSA 1 identified as particularly problematic pathogens A. baumannii and
More informationComparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria
Comparative Assessment of b-lactamases Produced by Multidrug Resistant Bacteria Juhee Ahn Department of Medical Biomaterials Engineering Kangwon National University October 23, 27 Antibiotic Development
More informationESBL- and carbapenemase-producing microorganisms; state of the art. Laurent POIREL
ESBL- and carbapenemase-producing microorganisms; state of the art Laurent POIREL Medical and Molecular Microbiology Unit Dept of Medicine University of Fribourg Switzerland INSERM U914 «Emerging Resistance
More informationAntimicrobial Resistance Strains
Antimicrobial Resistance Strains Microbiologics offers a wide range of strains with characterized antimicrobial resistance mechanisms including: Extended-Spectrum β-lactamases (ESBLs) Carbapenamases Vancomycin-Resistant
More informationβ-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa March 2018
β-lactams resistance among Enterobacteriaceae in Morocco 1 st ICREID Addis Ababa 12-14 March 2018 Antibiotic resistance center Institut Pasteur du Maroc Enterobacteriaceae (E. coli, Salmonella, ) S. aureus
More informationIntrinsic, implied and default resistance
Appendix A Intrinsic, implied and default resistance Magiorakos et al. [1] and CLSI [2] are our primary sources of information on intrinsic resistance. Sanford et al. [3] and Gilbert et al. [4] have been
More informationESBL Producers An Increasing Problem: An Overview Of An Underrated Threat
ESBL Producers An Increasing Problem: An Overview Of An Underrated Threat Hicham Ezzat Professor of Microbiology and Immunology Cairo University Introduction 1 Since the 1980s there have been dramatic
More informationMICRONAUT MICRONAUT-S Detection of Resistance Mechanisms. Innovation with Integrity BMD MIC
MICRONAUT Detection of Resistance Mechanisms Innovation with Integrity BMD MIC Automated and Customized Susceptibility Testing For detection of resistance mechanisms and specific resistances of clinical
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control as recommended by EUCAST Version 5.0, valid from 015-01-09 This document should be cited as "The
More informationOvernight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients
TABLE 1. Origin and carbapenem resistance characteristics of the 64 Acinetobacter baumannii stock D-750 Overnight identification of imipenem-resistant Acinetobacter baumannii carriage in hospitalized patients
More informationEXTENDED-SPECTRUM BETA-LACTAMASES EMERGING GRAM-NEGATIVE ORGANISMS
EXTENDED-SPECTRUM BETA-LACTAMASES EMERGING GRAM-NEGATIVE ORGANISMS David J. Feola, Pharm.D., Ph.D. Assistant Professor University of Kentucky College of Pharmacy Disclosures Research Funding Pfizer Objectives
More informationPresenter: Ombeva Malande. Red Cross Children's Hospital Paed ID /University of Cape Town Friday 6 November 2015: Session:- Paediatric ID Update
Emergence of invasive Carbapenem Resistant Enterobacteriaceae CRE infection at RCWMCH Ombeva Oliver Malande, Annerie du Plessis, Colleen Bamford, Brian Eley Presenter: Ombeva Malande Red Cross Children's
More informationSuggestions for appropriate agents to include in routine antimicrobial susceptibility testing
Suggestions for appropriate agents to include in routine antimicrobial susceptibility testing These suggestions are intended to indicate minimum sets of agents to test routinely in a diagnostic laboratory
More informationFighting MDR Pathogens in the ICU
Fighting MDR Pathogens in the ICU Dr. Murat Akova Hacettepe University School of Medicine, Department of Infectious Diseases, Ankara, Turkey 1 50.000 deaths each year in US and Europe due to antimicrobial
More informationHelp with moving disc diffusion methods from BSAC to EUCAST. Media BSAC EUCAST
Help with moving disc diffusion methods from BSAC to EUCAST This document sets out the main differences between the BSAC and EUCAST disc diffusion methods with specific emphasis on preparation prior to
More informationEXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING
EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING CHN61: EXTENDED-SPECTRUM BETA-LACTAMASE (ESBL) TESTING 1.1 Introduction A common mechanism of bacterial resistance to beta-lactam antibiotics is the production
More information2015 Antimicrobial Susceptibility Report
Gram negative Sepsis Outcome Programme (GNSOP) 2015 Antimicrobial Susceptibility Report Prepared by A/Professor Thomas Gottlieb Concord Hospital Sydney Jan Bell The University of Adelaide Adelaide On behalf
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationPROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains
PROTOCOL for serotyping and antimicrobial susceptibility testing of Salmonella test strains 1 INTRODUCTION... 1 2 OBJECTIVES... 2 3 OUTLINE OF THE EQAS 2017... 2 3.1 Shipping, receipt and storage of strains...
More informationMili Rani Saha and Sanya Tahmina Jhora. Department of Microbiology, Sir Salimullah Medical College, Mitford, Dhaka, Bangladesh
Detection of extended spectrum beta-lactamase producing Gram-negative organisms: hospital prevalence and comparison of double disc synergy and E-test methods Mili Rani Saha and Sanya Tahmina Jhora Original
More informationEUCAST recommended strains for internal quality control
EUCAST recommended strains for internal quality control Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus influenzae ATCC 59 ATCC
More informationINCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS
INCIDENCE OF BACTERIAL COLONISATION IN HOSPITALISED PATIENTS WITH DRUG-RESISTANT TUBERCULOSIS 1 Research Associate, Drug Utilisation Research Unit, Nelson Mandela University 2 Human Sciences Research Council,
More informationThe impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker
The impact of antimicrobial resistance on enteric infections in Vietnam Dr Stephen Baker sbaker@oucru.org Oxford University Clinical Research Unit, Ho Chi Minh City, Vietnam Outline The impact of antimicrobial
More informationRoutine internal quality control as recommended by EUCAST Version 3.1, valid from
Routine internal quality control as recommended by EUCAST Version.1, valid from 01-01-01 Escherichia coli Pseudomonas aeruginosa Staphylococcus aureus Enterococcus faecalis Streptococcus pneumoniae Haemophilus
More informationEuropean Committee on Antimicrobial Susceptibility Testing
European Committee on Antimicrobial Susceptibility Testing Routine and extended internal quality control for MIC determination and disk diffusion as recommended by EUCAST Version 8.0, valid from 018-01-01
More informationPrevalence of Extended Spectrum Beta- Lactamase Producers among Various Clinical Samples in a Tertiary Care Hospital: Kurnool District, India
International Journal of Current Microbiology and Applied Sciences ISSN: 319-77 Volume Number (17) pp. 57-3 Journal homepage: http://www.ijcmas.com Original Research Article https://doi.org/1.5/ijcmas.17..31
More informationDetection of Inducible AmpC β-lactamase-producing Gram-Negative Bacteria in a Teaching Tertiary Care Hospital in North India
Original Article Vol. 25 No. 3 Ampc β-lactamase Production in Gram-Negative Bacilli:-Chaudhary U, et al. 129 Detection of Inducible AmpC β-lactamase-producing Gram-Negative Bacteria in a Teaching Tertiary
More informationMechanism of antibiotic resistance
Mechanism of antibiotic resistance Dr.Siriwoot Sookkhee Ph.D (Biopharmaceutics) Department of Microbiology Faculty of Medicine, Chiang Mai University Antibiotic resistance Cross-resistance : resistance
More informationAntimicrobial Susceptibility Testing: Advanced Course
Antimicrobial Susceptibility Testing: Advanced Course Cascade Reporting Cascade Reporting I. Selecting Antimicrobial Agents for Testing and Reporting Selection of the most appropriate antimicrobials to
More informationGeorgios Meletis, Efstathios Oustas, Christina Botziori, Eleni Kakasi, Asimoula Koteli
New Microbiologica, 38, 417-421, 2015 Containment of carbapenem resistance rates of Klebsiella pneumoniae and Acinetobacter baumannii in a Greek hospital with a concomitant increase in colistin, gentamicin
More informationHelen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
METHODS USED IN NEW ZEALAND DIAGNOSTIC LABORATORIES TO IDENTIFY AND REPORT EXTENDED-SPECTRUM β-lactamase- PRODUCING ENTEROBACTERIACEAE by Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory
More informationTHE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS
THE NAC CHALLENGE PANEL OF ISOLATES FOR VERIFICATION OF ANTIBIOTIC SUSCEPTIBILITY TESTING METHODS Stefanie Desmet University Hospitals Leuven Laboratory medicine microbiology stefanie.desmet@uzleuven.be
More informationWhat does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh
What does multiresistance actually mean? Yohei Doi, MD, PhD University of Pittsburgh Disclosures Merck Research grant Clinical context of multiresistance Resistance to more classes of agents Less options
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXIII NUMBER 1 July 2008 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell, SM (ASCP), Marti Roe SM (ASCP), Ann-Christine Nyquist MD, MSPH Are the bugs winning? The 2007
More informationBreaking the Ring. β-lactamases and the Great Arms Race. Bryce M Kayhart, PharmD, BCPS PGY2 Pharmacotherapy Resident Mayo Clinic - Rochester
Breaking the Ring β-lactamases and the Great Arms Race Bryce M Kayhart, PharmD, BCPS PGY2 Pharmacotherapy Resident Mayo Clinic - Rochester 2015 MFMER slide-1 Disclosures I have no relevant financial relationships
More informationORIGINAL ARTICLE /j x. Mallorca, Spain
ORIGINAL ARTICLE 10.1111/j.1469-0691.2005.01251.x Contribution of clonal dissemination and selection of mutants during therapy to Pseudomonas aeruginosa antimicrobial resistance in an intensive care unit
More informationG. Valenza, S. Müller, C. Schmitt, D. Turnwald, T-T. Lam, M. Frosch, M. Abele-Horn, Y. Pfeifer
Evaluation of the VITEK AST-N1 card for detection of extended-spectrum beta-lactamases (ESBLs) in and compared to ESBL Etests and combination disk methods G. Valenza, S. Müller, C. Schmitt, D. Turnwald,
More informationMulti-drug resistant microorganisms
Multi-drug resistant microorganisms Arzu TOPELI Director of MICU Hacettepe University Faculty of Medicine, Ankara-Turkey Council Member of WFSICCM Deaths in the US declined by 220 per 100,000 with the
More informationMicrobiology. Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention. Antimicrobial resistance / MDR:
Microbiology Multi-Drug-Resistant bacteria / MDR: laboratory diagnostics and prevention June 2017 MeshHp (VS) Medical Care Center Dr. Eberhard & Partner Dortmund (ÜBAG) www.labmed.de MVZ Dr. Eberhard &
More informationTaiwan Surveillance of Antimicrobial Resistance (TSAR)
Taiwan Surveillance of Antimicrobial Resistance (TSAR) 2009 MIRL Symposium July 17, 2009 Tsai-Ling Yang Lauderdale ( ) Microbial Infections Reference Laboratory (MIRL) Division of Infectious Diseases,
More information5/4/2018. Multidrug Resistant Organisms (MDROs) Objectives. Outline. Define a multi-drug resistant organism (MDRO)
Multidrug Resistant Organisms (MDROs) Kasturi Shrestha, M.D. 05/11/2018 Objectives Define a multi-drug resistant organism (MDRO) Identify most challenging MDROs in healthcare Identify reasons for health
More informationa. 379 laboratories provided quantitative results, e.g (DD method) to 35.4% (MIC method) of all participants; see Table 2.
AND QUANTITATIVE PRECISION (SAMPLE UR-01, 2017) Background and Plan of Analysis Sample UR-01 (2017) was sent to API participants as a simulated urine culture for recognition of a significant pathogen colony
More informationDefining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate Confirmation Testing
Infect Dis Ther (2015) 4:513 518 DOI 10.1007/s40121-015-0094-6 BRIEF REPORT Defining Extended Spectrum b-lactamases: Implications of Minimum Inhibitory Concentration- Based Screening Versus Clavulanate
More informationWitchcraft for Gram negatives
Witchcraft for Gram negatives Dr Subramanian S MD DNB MNAMS AB (Medicine, Infect Dis) Infectious Diseases Consultant Global Health City, Chennai www.asksubra.com Drug resistance follows the drug like a
More informationCharacterization of isolates from a multi-drug resistant outbreak of Shiga toxin-producing Escherichia. coli O145 infections in the United States
AAC Accepts, published online ahead of print on 19 September 2011 Antimicrob. Agents Chemother. doi:10.1128/aac.05545-11 Copyright 2011, American Society for Microbiology and/or the Listed Authors/Institutions.
More informationAddressing the evolving challenge of β-lactamase mediated antimicrobial resistance: ETX2514, a next-generation BLI with potent broadspectrum
Addressing the evolving challenge of β-lactamase mediated antimicrobial resistance: ETX2514, a next-generation BLI with potent broadspectrum activity against Class A, C and D enzymes Alita Miller, PhD
More informationInternational Journal of Pharma and Bio Sciences ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI ABSTRACT
Research Article Microbiology International Journal of Pharma and Bio Sciences ISSN 0975-6299 ANTIMICROBIAL SUSCEPTIBILITY PATTERN OF ESBL PRODUCING GRAM NEGATIVE BACILLI * PRABHAKAR C MAILAPUR, DEEPA
More informationDR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA
DR. MICHAEL A. BORG DIRECTOR OF INFECTION PREVENTION & CONTROL MATER DEI HOSPITAL - MALTA The good old days The dread (of) infections that used to rage through the whole communities is muted Their retreat
More informationMichael Hombach*, Guido V. Bloemberg and Erik C. Böttger
J Antimicrob Chemother 2012; 67: 622 632 doi:10.1093/jac/dkr524 Advance Access publication 13 December 2011 Effects of clinical breakpoint changes in CLSI guidelines 2010/2011 and EUCAST guidelines 2011
More informationAntibiotic resistance a mechanistic overview Neil Woodford
Antibiotic Resistance a Mechanistic verview BSc PhD FRCPath Consultant Clinical Scientist 1 Polymyxin Colistin Daptomycin Mechanisms of antibiotic action Quinolones Mupirocin Nitrofurans Nitroimidazoles
More informationIn veterinary medicine, beta-lactam antibiotics are arguably
MICROBIAL DRUG RESISTANCE Volume 22, Number 4, 2016 ª Mary Ann Liebert, Inc. DOI: 10.1089/mdr.2015.0196 Emergence of Carbapenemase-Producing Escherichia coli Isolated from Companion Animals in Algeria
More informationETX2514: Responding to the global threat of nosocomial multidrug and extremely drug resistant Gram-negative pathogens
ETX2514: Responding to the global threat of nosocomial multidrug and extremely drug resistant Gram-negative pathogens Ruben Tommasi, PhD Chief Scientific Officer ECCMID 2017 April 24, 2017 Vienna, Austria
More informationDr Vivien CHUANG Associate Consultant Infection Control Branch, Centre for Health Protection/ Infectious Disease Control and Training Center,
Dr Vivien CHUANG Associate Consultant Infection Control Branch, Centre for Health Protection/ Infectious Disease Control and Training Center, Hospital Authority NDM-1, which stands for New Delhi Metallo-beta-lactamase-1
More informationResearch & Reviews: Journal of Veterinary Sciences
Research & Reviews: Journal of Veterinary Sciences Antimicrobial Susceptibility Pattern of Gram Negative Bacteria Isolated from Feline Urinary Tract Infections (UTIs): A Retrospective Study from 2011 to
More informationAPPENDIX III - DOUBLE DISK TEST FOR ESBL
Policy # MI\ANTI\04\03\v03 Page 1 of 5 Section: Antimicrobial Susceptibility Testing Manual Subject Title: Appendix III - Double Disk Test for ESBL Issued by: LABORATORY MANAGER Original Date: January
More informationgroup and their transferability in resistant clinical isolates of Salmonella serogroups from several hospitals of Tehran
Volume 7 Number 4 (August 2015) 203-207 ORIGINAL ARTICLE Prevalence of the bla CTX-M-1 group and their transferability in resistant clinical isolates of Salmonella serogroups from several hospitals of
More informationCo-transfer of bla NDM-5 and mcr-1 by an IncX3 X4 hybrid plasmid in Escherichia coli 4
SUPPLEMENTARY INFORMATION ARTICLE NUMBER: 16176 DOI: 10.1038/NMICROBIOL.2016.176 Co-transfer of bla NDM-5 and mcr-1 by an IncX3 X4 hybrid plasmid in Escherichia coli 4 5 6 7 8 9 10 11 12 13 14 15 16 17
More informationPrevention, Management, and Reporting of Carbapenem-Resistant Enterobacteriaceae
Prevention, Management, and Reporting of Carbapenem-Resistant Enterobacteriaceae Dawn Terashita MD, MPH Acute Communicable Disease Control Los Angeles County Department of Public Health September 28, 2017
More informationWhat s new in EUCAST methods?
What s new in EUCAST methods? Derek Brown EUCAST Scientific Secretary Interactive question 1 MIC determination MH-F broth for broth microdilution testing of fastidious microorganisms Gradient MIC tests
More informationMount Sinai Hospital/University Health Network, Department of Microbiology, Toronto, Ontario, Canada 3
Brief Original Article New Delhi metallo-β-lactamase in Jamaica Camille-Ann Thoms-Rodriguez 1, Tony Mazzulli 2,3, Nicole Christian 1, Barbara M Willey 2, David A Boyd 4, Laura F Mataseje 4, Michael R Mulvey
More informationAntibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
Antimicrobial susceptibility of Shigella, 2015 and 2016 Helen Heffernan and Rosemary Woodhouse Antibiotic Reference Laboratory, Institute of Environmental Science and Research Limited (ESR); August 2017
More informationcrossm Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-negative pathogens between
RESEARCH ARTICLE Clinical Science and Epidemiology crossm Global Assessment of the Activity of Tigecycline against Multidrug-Resistant Gram-Negative Pathogens between 2004 and 2014 as Part of the Tigecycline
More informationMechanisms and Pathways of AMR in the environment
FMM/RAS/298: Strengthening capacities, policies and national action plans on prudent and responsible use of antimicrobials in fisheries Final Workshop in cooperation with AVA Singapore and INFOFISH 12-14
More informationEDUCATIONAL COMMENTARY THE RISE OF CARBAPENEM-RESISTANT ENTEROBACTERIACEAE
ENTEROBACTERIACEAE Educational commentary is provided through our affiliation with the American Society for Clinical Pathology (ASCP). To obtain FREE CME/CMLE credits click on Earn CE Credits under Continuing
More information2015 Antibiogram. Red Deer Regional Hospital. Central Zone. Alberta Health Services
2015 Antibiogram Red Deer Regional Hospital Central Zone Alberta Health Services Introduction. This antibiogram is a cumulative report of the antimicrobial susceptibility rates of common microbial pathogens
More informationAvailable online at ISSN No:
Available online at www.ijmrhs.com ISSN No: 2319-5886 International Journal of Medical Research & Health Sciences, 2017, 6(4): 36-42 Comparative Evaluation of In-Vitro Doripenem Susceptibility with Other
More informationCONTAGIOUS COMMENTS Department of Epidemiology
VOLUME XXXII NUMBER 6 September 2017 CONTAGIOUS COMMENTS Department of Epidemiology Bugs and Drugs Elaine Dowell SM MLS (ASCP), Stacey Hamilton MT SM (ASCP), Samuel Dominguez MD PhD, Sarah Parker MD, and
More informationجداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی
جداول میکروارگانیسم های بیماریزای اولویت دار و آنتی بیوتیک های تعیین شده برای آزمایش تعیین حساسیت ضد میکروبی در برنامه مهار مقاومت میکروبی ویرایش دوم بر اساس ed., 2017 CLSI M100 27 th تابستان ۶۹۳۱ تهیه
More informationEARS Net Report, Quarter
EARS Net Report, Quarter 4 213 March 214 Key Points for 213* Escherichia coli: The proportion of patients with invasive infections caused by E. coli producing extended spectrum β lactamases (ESBLs) increased
More informationWhat do we know about multidrug resistant bacteria in New Zealand s pet animals?
What do we know about multidrug resistant bacteria in New Zealand s pet animals? Eve Pleydell Animal and Marine Biosecurity Response Team, Ministry for Primary Industries Formerly: Institute of Veterinary,
More information2012 ANTIBIOGRAM. Central Zone Former DTHR Sites. Department of Pathology and Laboratory Medicine
2012 ANTIBIOGRAM Central Zone Former DTHR Sites Department of Pathology and Laboratory Medicine Medically Relevant Pathogens Based on Gram Morphology Gram-negative Bacilli Lactose Fermenters Non-lactose
More informationJOURNAL OF INTERNATIONAL ACADEMIC RESEARCH FOR MULTIDISCIPLINARY Impact Factor 1.625, ISSN: , Volume 3, Issue 4, May 2015
PHENOTYPIC DETECTION OF FAECAL CARRIAGE EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE IN HILLA CITY Dr. FATIMA MOEEN ABBAS* *Dept. of Biology, College of Sciences for Women, University
More informationJournal of Antimicrobial Chemotherapy Advance Access published October 3, 2011
Journal of Antimicrobial Chemotherapy Advance Access published October 3, 2011 J Antimicrob Chemother doi:10.1093/jac/dkr400 Comparison of European Committee on Antimicrobial Susceptibility Testing (EUCAST)
More informationRise of Resistance: From MRSA to CRE
Rise of Resistance: From MRSA to CRE Paul D. Holtom, MD Professor of Medicine and Orthopaedics USC Keck School of Medicine SUPERBUGS (AKA MDROs) MRSA Methicillin-resistant S. aureus Evolution of Drug Resistance
More informationJanuary 2014 Vol. 34 No. 1
January 2014 Vol. 34 No. 1. and Minimal Inhibitory Concentration (MIC) Interpretive Standards for Testing Conditions Medium: diffusion: Mueller-Hinton agar (MHA) roth dilution: cation-adjusted Mueller-Hinton
More informationNew Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs
New Opportunities for Microbiology Labs to Add Value to Antimicrobial Stewardship Programs Patrick R. Murray, PhD Senior Director, WW Scientific Affairs 2017 BD. BD, the BD Logo and all other trademarks
More informationAntimicrobial susceptibility of Salmonella, 2015
Antimicrobial susceptibility of Salmonella, 2015 Hospital and community laboratories are requested to refer all Salmonella isolated from human salmonellosis cases to ESR for serotyping and the laboratory-based
More informationResearch, National Health Research Institute, Zhunan, Taiwan. Received: May 1, 2008 Revised: June 4, 2008 Accepted: July 4, 2008
J Microbiol Immunol Infect. 2009;42:310-316 Prevalence of extended-spectrum β-lactamases in Enterobacter cloacae in Taiwan and comparison of 3 phenotypic confirmatory methods for detecting extended-spectrum
More informationOrigins of Resistance and Resistance Transfer: Food-Producing Animals.
Origins of Resistance and Resistance Transfer: Food-Producing Animals. Chris Teale, AHVLA. Origins of Resistance. Mutation Brachyspira hyodysenteriae and macrolide and pleuromutilin resistance. Campylobacter
More informationComparison of in vitro efficacy of ertapenem, imipenem and meropenem by the Enterobacteriaceae strains family
ORIGINAL AND CLINICAL ARTICLES Anaesthesiology Intensive Therapy 2013, vol. 45, no 2, 67 72 ISSN 1642 5758 DOI: 10.5603/AIT.2013.0015 www.ait.viamedica.pl Comparison of in vitro efficacy of ertapenem,
More informationReceived 14 August 2004/Returned for modification 8 November 2004/Accepted 1 May 2005
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, Aug. 2005, p. 3533 3537 Vol. 49, No. 8 0066-4804/05/$08.00 0 doi:10.1128/aac.49.8.3533 3537.2005 Copyright 2005, American Society for Microbiology. All Rights Reserved.
More informationNova Journal of Medical and Biological Sciences Page: 1
Nova Explore Publications Nova Journal of Medical and Biological Sciences Vol. 3(1), 2014:1-5 PII: S2292793X1400003-3 www.novaexplore.com Multidrug resistance of Enterobacter Aerogenes isolated from bovine
More informationPhenotypic Characterization of Non-Beta Lactam Multidrug Resistance in Extended-Spectrum Beta-Lactamase Producer and Non- Producer Enterobacteriaceae
Research Article imedpub Journals www.imedpub.com DOI: 10.21767/2472-1093.100039 Journal of Infectious Diseases and Treatment Phenotypic Characterization of Non-Beta Lactam Multidrug Resistance in Extended-Spectrum
More informationAntimicrobial susceptibility of Salmonella, 2016
susceptibility of Salmonella, 06 Hospital and community laboratories are requested to refer all Salmonella isolated from human salmonellosis cases to ESR for serotyping and the laboratory-based surveillance
More informationHelen Heffernan. Rosemary Woodhouse
ANTIMICROBIAL RESISTANCE AMONG GRAM-NEGATIVE BACILLI FROM BACTERAEMIA, 2007 Helen Heffernan Rosemary Woodhouse Antibiotic Reference Laboratory Communicable Disease Group Institute of Environmental Science
More informationAntimicrobial Susceptibility Testing: The Basics
Antimicrobial Susceptibility Testing: The Basics Susan E. Sharp, Ph.D., DABMM, FAAM Director, Airport Way Regional Laboratory Director, Regional Microbiology and Molecular Infectious Diseases Laboratories
More informationActivity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia coli and Klebsiella pneumoniae from New York City
Journal of Antimicrobial Chemotherapy Advance Access published July 31, 2010 J Antimicrob Chemother doi:10.1093/jac/dkq278 Activity of a novel aminoglycoside, ACHN-490, against clinical isolates of Escherichia
More informationThe Basics: Using CLSI Antimicrobial Susceptibility Testing Standards
The Basics: Using CLSI Antimicrobial Susceptibility Testing Standards Janet A. Hindler, MCLS, MT(ASCP) UCLA Health System Los Angeles, California, USA jhindler@ucla.edu 1 Learning Objectives Describe information
More informationSafe Patient Care Keeping our Residents Safe Use Standard Precautions for ALL Residents at ALL times
Safe Patient Care Keeping our Residents Safe 2016 Use Standard Precautions for ALL Residents at ALL times #safepatientcare Do bugs need drugs? Dr Deirdre O Brien Consultant Microbiologist Mercy University
More informationOriginal Article. Ratri Hortiwakul, M.Sc.*, Pantip Chayakul, M.D.*, Natnicha Ingviya, B.Sc.**
Original Article In Vitro Activity of Cefminox and Other β-lactam Antibiotics Against Clinical Isolates of Extended- Spectrum-β-lactamase-Producing Klebsiella pneumoniae and Escherichia coli Ratri Hortiwakul,
More informationAntimicrobial Resistance: A Growing Concern for Healthcare Security and Resilience
Antimicrobial Resistance: A Growing Concern for Healthcare Security and Resilience Neil Woodford HPA AMRHAI - Colindale Resistance is entirely natural...and is ancient Permafrost samples Late Pleistocene
More information